Literature DB >> 110876

Vaccination against influenza: a five-year study in the Post Office.

J W Smith, R Pollard.   

Abstract

An injection of influenza vaccine was offered to approximately 60 000 Postal and Telecommunications staff at the beginning of five successive winters. The sickness absence of this group, which included those who accepted the offer of vaccine as well as those who did not, was compared throughout the winter with that of a similar number of employees who were not offered vaccine. The two groups, ;vaccinated' and control, comprised the staff of nearly 400 Post Office units scattered throughout Great Britain, the units of the two groups being matched as far as practicable for numbers employed, type of work, region and type of location.The proportion who accepted vaccine fell from 42% in the first year (when only 26 000 Telecommunications employees were offered vaccine) to 35% in the second year, and 25% by the fifth year.With the exception of Telecommunications employees in 1972-73, the sickness absence rate of the group offered vaccine was less than that of the group not offered vaccine, and the difference was evident during the winter observation periods both when influenza was prevalent and when it was not. In the last four years of the study the average difference in sickness absence between the ;vaccinated' and control groups was 1.26 days per 100 employees per week during and 1.12 days outside the influenza periods. Moreover, the difference during the influenza periods was greater than could be expected from the acceptance rate of vaccine and the estimated attack rate of influenza. The apparent reduction in sickness absence of the group offered vaccine in comparison with the group not offered vaccine represented an appreciable saving in cost.It is suggested than an annual influenza vaccination campaign in industry may produce financial benefit, but that only a proportion of the benefit is due to an improvement in health.

Mesh:

Substances:

Year:  1979        PMID: 110876      PMCID: PMC2130105          DOI: 10.1017/s0022172400025936

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  8 in total

1.  Vaccination in the control of influenza.

Authors:  J W Smith; W B Fletcher; P J Wherry
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

2.  Influenza vaccination--acceptance in an industrial population.

Authors:  J W Smith; R Pollard; W B Fletcher; R Barker; J R Lewis
Journal:  Br J Ind Med       Date:  1974-10

3.  Vaccination in the control of influenza. Interim report to the Director of the Public Health Laboratory Service on a Collaborative Study with the Post Office.

Authors:  J W Smith
Journal:  Lancet       Date:  1974-08-10       Impact factor: 79.321

4.  Effectiveness of current killed influenza vaccines against influenza A-England-42-72.

Authors:  F L Ruben
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

5.  A clinical trial of influenza vaccine in Canberra.

Authors:  K W Edmondson; D S Graham; M F Warburton
Journal:  Med J Aust       Date:  1970-07-04       Impact factor: 7.738

6.  Reactions to injected influenza vaccine.

Authors:  J W Smith; W B Fletcher; P J Wherry
Journal:  Dev Biol Stand       Date:  1975

7.  Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response.

Authors:  M S Pereira; P Chakraverty; G C Schild; M T Coleman; W R Dowdle
Journal:  Br Med J       Date:  1972-12-23

8.  Sickness absence: facts and misconceptions.

Authors:  P Taylor
Journal:  J R Coll Physicians Lond       Date:  1974-07
  8 in total
  8 in total

Review 1.  Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence.

Authors:  M J Postma; R M Baltussen; M L Heijnen; L T de Berg; J C Jager
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

Review 2.  Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.

Authors:  Maarten J Postma; Paul Jansema; Marianne L L van Genugten; Marie-Louise A Heijnen; Johannes C Jager; Lolkje T W de Jong-van den Berg
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Economic evaluation of influenza vaccination and economic modelling. Can results be pooled?

Authors:  T Jefferson; V Demicheli
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

4.  Quantifying influenza vaccine efficacy and antigenic distance.

Authors:  Vishal Gupta; David J Earl; Michael W Deem
Journal:  Vaccine       Date:  2006-01-19       Impact factor: 3.641

5.  A comparison of adverse effects of two influenza vaccines, and the influence on subsequent uptake.

Authors:  M P Ryan; A F MacLeod
Journal:  J R Coll Gen Pract       Date:  1984-08

6.  Influenza 1980-1.

Authors: 
Journal:  Br Med J       Date:  1980-08-23

7.  Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.

Authors:  M L Clements; S O'Donnell; M M Levine; R M Chanock; B R Murphy
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

8.  Humoral and cellular responses of mice to infection with a cold-adapted influenza A virus variant.

Authors:  N K Mak; Y H Zhang; G L Ada; G A Tannock
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.